SBRA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
230.1M
+3.8%
221.8M
-9.5%
245.0M
+38.1%
177.4M
-0.8%
178.8M
Cost of Revenue
0
0
0
0
0
Gross Profit
230.1M
+3.8%
221.8M
-9.5%
245.0M
+38.1%
177.4M
-0.8%
178.8M
Operating Expenses
267.9M
+74.1%
153.9M
+4.0%
148.0M
+11.2%
133.1M
+9.9%
121.1M
R&D
0
0
0
0
0
SG&A
16.8M
+13.2%
14.9M
-6.6%
15.9M
+26.7%
12.6M
+0.4%
12.5M
Operating Income
-37805000
-155.7%
67.9M
-30.0%
97.0M
+118.9%
44.3M
-23.2%
57.7M
EBITDA
18.6M
-84.7%
121.5M
-18.5%
149.1M
+56.2%
95.4M
-9.5%
105.4M
Net Income
-25248000
-161.9%
40.8M
+50.3%
27.1M
+20.6%
22.5M
-65.6%
65.5M
EPS (Basic)
$-0.10
-162.5%
$0.16
+45.5%
$0.11
+22.2%
$0.09
-67.9%
$0.28
EPS (Diluted)
$-0.10
-162.5%
$0.16
+45.5%
$0.11
+22.2%
$0.09
-66.7%
$0.27
Shares (Diluted)
252.3M
-1.4%
256.0M
+1.1%
253.2M
+4.0%
243.6M
+1.1%
240.9M
Sabra Healthcare REIT (SBRA) โ€” Financials